ALNEV — Neovacs SA Share News
0.000.00%
Last trade - 00:00- €0.01m
- -€0.03m
- €0.16m
Brief: Neovacs: Signia Therapeutics Awarded EUR 1.7 Mln Grant From Bpifrance
Brief: Neovacs To Implement Shares Consolidation
Brief: Neovacs Announces Suspension Of OCEANE-BSA Financing Agreement Use
Brief: Neovacs Says Atlas Special Opportunities Proposal Rejected
Brief: Neovacs H1 Net Loss Shrinks To 3.2 Million Euros
Brief: Neovacs Invests 4.2 Mln In COVID-19 Screening Company Bio Detection K9
Brief: Neovacs Unveils 80 Million Euro Investment Program For Coming Years
Brief: Neovacs Announces End Of OCEANE-BSA Programme
Brief: Neovacs Announces Capital Rise Of 2 Million Euros
Brief: Neovacs Raises 4 Million Euros From 4 Tranches Of Convertible Bonds
Brief: Neovacs Announces Eur 2 Million Capital Increase
Brief: Neovacs Raises Eur 2 Mln By Drawdown Of 2 Tranches Of OCEANE-BSA
Brief: Neovacs Announces Fundraising Of EUR 4 Million Through The Issue Of 4 Tranches Of Of OCEANE-Bsa
Brief: Neovacs Announces Fundraising Of 2 Millions Euros
Brief: Neovacs: Fundraising Of EUR 2 Million
Brief: Neovacs To Continue Trials On New Vaccine Candidates For Allergies
Brief: Neovacs Announces EUR 3 Mln Funds Raise
Brief: Neovacs Is Studying Four Investment Opportunities In Innovative Companies
Brief: Neovacs Announces A Capital Rise Of EUR 2 Mln